Potential increase in androgen sensitivity following antisense oligonucleotide suppression of Bcl-2 in a prostate cancer model.

被引：0
|
作者：
Guinan, Patrick
Rubenstein, Marvin
Hollowell, Courtney M. P.
机构：
[1] Hektoen Inst Med Res, Chicago, IL 60612 USA
[2] John H Stroger Jr Hosp Cook Cty, Chicago, IL USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2012年 / 30卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e13532
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Regulation of Bcl-2 during androgen-unresponsive progression of prostate cancer
    Rothermund, CA
    Kondrikov, D
    Lin, MF
    Vishwanatha, JK
    PROSTATE CANCER AND PROSTATIC DISEASES, 2002, 5 (03) : 236 - 245
  • [22] Androgen deprivation therapy affects BCL-2 expression in human prostate cancer
    Fuzio, Paolo
    Ditonno, Pasquale
    Lucarelli, Giuseppe
    Battaglia, Michele
    Bettocchi, Carlo
    Senia, Trabucco
    Perlino, Elda
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2011, 39 (05) : 1233 - 1242
  • [23] Regulation of Bcl-2 during androgen-unresponsive progression of prostate cancer
    C A Rothermund
    D Kondrikov
    M-F Lin
    J K Vishwanatha
    Prostate Cancer and Prostatic Diseases, 2002, 5 : 236 - 245
  • [24] Induction of apoptosis and enhancement of chemosensitivity in human prostate cancer LNCaP cells using bispecific antisense oligonucleotide targeting Bcl-2 and Bcl-xL genes
    Yamanaka, Kazuki
    Rocchi, Palma
    Miyake, Hideaki
    Fazli, Ladan
    So, Alan
    Zangemeister-Wittle, Uwe
    Gleave, Martin E.
    BJU INTERNATIONAL, 2006, 97 (06) : 1300 - 1308
  • [25] Bcl-2 antisense oligonucleotides: A potential novel strategy for the treatment of breast cancer
    Nahta, R
    Esteva, FJ
    SEMINARS IN ONCOLOGY, 2003, 30 (05) : 143 - 149
  • [26] Therapeutic potential of antisense Bcl-2 as a chemosensitizer for patients with breast cancer.
    Kim, R
    Emi, M
    Tanabe, K
    BREAST CANCER RESEARCH AND TREATMENT, 2005, 94 : S284 - S284
  • [27] Remarkable induction of apoptosis in cancer cells by a novel cationic liposome complexed with a bcl-2 antisense oligonucleotide
    Noguchi, S
    Hirashima, N
    Furuno, T
    Nakanishi, M
    JOURNAL OF CONTROLLED RELEASE, 2003, 88 (02) : 313 - 320
  • [28] Effects of Bcl-2 modulation with G3139 antisense oligonucleotide on human breast cancer cells are independent of inherent Bcl-2 protein expression
    Kim N. Chi
    Anne E. Wallis
    Chow Hwee Lee
    Daniel Lopez de Menezes
    Jason Sartor
    Wieslawa H. Dragowska
    Lawrence D. Mayer
    Breast Cancer Research and Treatment, 2000, 63 : 199 - 212
  • [29] Effects of Bcl-2 modulation with G3139 antisense oligonucleotide on human breast cancer cells are independent of inherent Bcl-2 protein expression
    Chi, KN
    Wallis, AE
    Lee, CH
    de Menezes, DL
    Sartor, J
    Dragowska, WH
    Mayer, LD
    BREAST CANCER RESEARCH AND TREATMENT, 2000, 63 (03) : 199 - 212
  • [30] Androgen signaling and post-transcriptional downregulation of Bcl-2 in androgen-unresponsive prostate cancer
    C A Rothermund
    V K Gopalakrishnan
    J K Vishwanatha
    Prostate Cancer and Prostatic Diseases, 2004, 7 : 158 - 164
12345